GeoVax Labs, Inc.(GOVX)

Description: GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.

---

Keywords: Biotechnology Cancer Clinical Medicine Infectious Diseases Vaccines Allergy Immunotherapies HIV Hepatitis B Virology Viruses Department Of Defense Virus Fever Immunodeficiency Malaria Ebola U.S. Department Of Defense Chronic Hepatitis Scripps Zika Hiv Vaccine Centers For Disease Control And Prevention Emory University Modified Vaccinia Ankara Vaccinia

---

Home Page: www.geovax.com

GOVX Technical Analysis

1900 Lake Park Drive
Smyrna, GA 30080
United States
Phone: 678 384 7220

---

Officers

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)